{
  "study_identification": {
    "study_id": "Zheng2024",
    "reference_file_names": "Zheng2024.pdf.md; Zheng2024_sup.pdf.md",
    "author_journal_year": "Zheng et al., Psychological Medicine, 2024",
    "title": "Characterizing the distinct imaging phenotypes, clinical behavior, and genetic vulnerability of brain maturational subtypes in mood disorders",
    "doi": "10.1017/S0033291724000886"
  },
  "study_characteristics": {
    "study_objective": "To quantify individual-level gray matter volume (GMV) deviations via normative modeling to identify maturational subtypes in mood disorders and characterize their clinical, transcriptomic, and genetic differences; and to validate imaging-based subtyping in an independent replication cohort.",
    "study_design": "Cross-sectional",
    "study_design_other": "-"
  },
  "reference_cohort_and_imaging": {
    "dataset_name": {
      "Answer": "Single-site local cohort (First Affiliated Hospital of China Medical University, Shenyang)",
      "Confidence Rating": "High",
      "Negative Answer Category": "Not Negative",
      "Reason": "Participants (patients and HC) were recruited and scanned at the same hospital/site; no external public dataset used.",
      "Supporting Text": "All the patients were recruited … Department of Psychiatry of the First Affiliated Hospital of China Medical University … HC participants were recruited from the local community … Structural MRI scanning was conducted … at the First Affiliated Hospital, China Medical University.",
      "Page/Line": "materials/Zheng2024.pdf.md: lines 69-76; materials/Zheng2024_sup.pdf.md: lines 25-31"
    },
    "hc_n": {
      "Answer": "404",
      "Confidence Rating": "High",
      "Negative Answer Category": "Not Negative",
      "Reason": "Explicitly states number of healthy controls in discovery dataset.",
      "Supporting Text": "We recruited 114 MDD patients, 60 BD patients and 404 healthy controls (HC).",
      "Page/Line": "materials/Zheng2024.pdf.md: line 69"
    },
    "hc_age": {
      "Answer": "mean 29.0; sd 9.3; range NR",
      "Confidence Rating": "High",
      "Negative Answer Category": "Not Negative",
      "Reason": "HC age (mean±SD) is provided in Supplementary Table S1; no range reported.",
      "Supporting Text": "Table S1 … Age | 29.0±9.3 (HC)",
      "Page/Line": "materials/Zheng2024_sup.pdf.md: lines 66-72"
    },
    "hc_sex": {
      "Answer": "F 244 (60.4%), M 160 (39.6%)",
      "Confidence Rating": "High",
      "Negative Answer Category": "Not Negative",
      "Reason": "Sex counts for HC are reported; percentages computed from N=404.",
      "Supporting Text": "Table S1 … Gender (male/female) | 160/244 (HC)",
      "Page/Line": "materials/Zheng2024_sup.pdf.md: lines 66-73"
    },
    "imaging_modality": {
      "Answer": "T1-weighted MRI",
      "Confidence Rating": "High",
      "Negative Answer Category": "Not Negative",
      "Reason": "Structural T1-weighted images acquired on 3.0T system.",
      "Supporting Text": "Structural MRI … T1-weighted images were acquired … three-dimensional fast spoiled gradient-echo.",
      "Page/Line": "materials/Zheng2024_sup.pdf.md: lines 27-31"
    },
    "analysis_level": {
      "Answer": "ROI-level",
      "Confidence Rating": "High",
      "Negative Answer Category": "Not Negative",
      "Reason": "Voxel-wise GMV was summarized to ROI-wise gray matter density using the 68-region Desikan–Killiany atlas for between-group analyses and subtyping inputs.",
      "Supporting Text": "The Desikan–Killiany (DK) parcellation … 68 cortical regions … ROI-wise gray matter density … used for investigating between-group differences.",
      "Page/Line": "materials/Zheng2024.pdf.md: lines 108-116"
    },
    "preprocessing_pipeline": {
      "Answer": "CAT12; SPM12; VBM; DARTEL normalization; DK atlas parcellation",
      "Confidence Rating": "High",
      "Negative Answer Category": "Not Negative",
      "Reason": "Preprocessing explicitly describes CAT12 in SPM12 with standard VBM steps, DARTEL normalization, and DK ROI parcellation.",
      "Supporting Text": "T1-weighted images were preprocessed using … CAT12 implemented in SPM12 … Diffeomorphic Anatomical Registration Exponentiated Lie Algebra … voxel-wise estimates of GMV … Desikan–Killiany parcellation … ROI-wise gray matter density.",
      "Page/Line": "materials/Zheng2024_sup.pdf.md: lines 31-33; materials/Zheng2024.pdf.md: lines 104-116"
    },
    "quality_checking": {
      "Answer": "Yes",
      "Confidence Rating": "High",
      "Negative Answer Category": "Not Negative",
      "Reason": "Automated QC using CAT12 IQR metrics with explicit pass/fail thresholds applied.",
      "Supporting Text": "The quality of images was assessed by … IQR … An image was classified as to fail QC if … We applied the cut-off (>=80%, >= grad B).",
      "Page/Line": "materials/Zheng2024_sup.pdf.md: lines 33-36"
    },
    "quality_checking_detail": {
      "Answer": "Automated CAT12 Image Quality Rating (IQR); fail if noise grade ≤ C (70%) and total IQR < B (80%); applied cutoff ≥80% (grade B) to include; overall IQR ~86.4%±0.74% (Dataset1) and 86.3%±0.72% (Dataset2).",
      "Confidence Rating": "High",
      "Negative Answer Category": "Not Negative",
      "Reason": "QC details and thresholds are explicitly provided with summary statistics.",
      "Supporting Text": "… percentage rating (0-100%) … fail QC if … noise grade ≤ 'C' (70%) and total IQR < 'B'(80%). … applied the cut-off (>=80%, >= grad B) … general IQR ratings … 86.4% ± 0.74% … 86.3% ± 0.72%.",
      "Page/Line": "materials/Zheng2024_sup.pdf.md: lines 33-37"
    },
    "site_effect_handling": {
      "Answer": "None",
      "Confidence Rating": "High",
      "Negative Answer Category": "Not Negative",
      "Reason": "Single-site acquisition on one scanner; no batch/site harmonization method described or required.",
      "Supporting Text": "Structural MRI scanning was conducted on a Signa HDx 3.0T … at the First Affiliated Hospital, China Medical University.",
      "Page/Line": "materials/Zheng2024_sup.pdf.md: lines 27-31"
    },
    "site_effect_handling_detail": {
      "Answer": "-",
      "Confidence Rating": "High",
      "Negative Answer Category": "Not Negative",
      "Reason": "Single-site study; no site/scanner harmonization approach applicable.",
      "Supporting Text": "Single scanner/site detailed in acquisition section; no mention of ComBat/HBR or similar.",
      "Page/Line": "materials/Zheng2024_sup.pdf.md: lines 27-31"
    }
  },
  "normative_modeling": {
    "model_origin": {
      "Answer": "New",
      "Confidence Rating": "High",
      "Negative Answer Category": "Not Negative",
      "Reason": "Normative curves were trained from the study's HC cohort using quantile regression.",
      "Supporting Text": "… created normative curves with age based on GMV in HC group … Quantile regression was used to obtain a normative range …",
      "Page/Line": "materials/Zheng2024.pdf.md: lines 100-108; 116-124"
    },
    "model_origin_detail": {
      "Answer": "-",
      "Confidence Rating": "High",
      "Negative Answer Category": "Not Negative",
      "Reason": "No external pre-trained model; normative model trained de novo on local HC.",
      "Supporting Text": "… quantile normative modeling to create maturation curves … based on HC group.",
      "Page/Line": "materials/Zheng2024.pdf.md: lines 100-108"
    },
    "modeling_method": {
      "Answer": "Quantile regression normative modeling (age- and sex-dependent GMV percentiles; z5/z50/z95 deviation scores)",
      "Confidence Rating": "High",
      "Negative Answer Category": "Not Negative",
      "Reason": "Methods section explicitly states quantile regression and the computation of deviation z-scores at 5th/50th/95th percentiles.",
      "Supporting Text": "Quantile regression was used … expressed … z5 … z50 … z95 … as individual deviation z-scores for each brain region.",
      "Page/Line": "materials/Zheng2024.pdf.md: lines 116-124"
    },
    "software_tool": {
      "Answer": "NR",
      "Confidence Rating": "Low",
      "Negative Answer Category": "Missing",
      "Reason": "Software/library for quantile regression not specified (e.g., R quantreg, Python).",
      "Supporting Text": "No mention of specific software for the normative modeling step.",
      "Page/Line": "materials/Zheng2024.pdf.md: normative modeling section (no tool named)"
    },
    "response_variable": {
      "Answer": "ROI-wise gray matter volume/density (Desikan–Killiany 68 cortical regions)",
      "Confidence Rating": "High",
      "Negative Answer Category": "Not Negative",
      "Reason": "GMV derived via VBM, summarized to DK ROIs and used to compute deviations and subtyping.",
      "Supporting Text": "Voxel wised gray matter density … Desikan–Killiany … ROI-wise gray matter density … used …",
      "Page/Line": "materials/Zheng2024.pdf.md: lines 104-116"
    },
    "predictor_variables": {
      "Answer": "Age; Sex",
      "Confidence Rating": "High",
      "Negative Answer Category": "Not Negative",
      "Reason": "Quantile regression modeled regional GMV as a function of age and sex.",
      "Supporting Text": "… normative range of regional GMV variation as a function of age and sex …",
      "Page/Line": "materials/Zheng2024.pdf.md: line 116"
    },
    "predictor_effects": {
      "Answer": "Age and Sex modeled as predictors in quantile regression; fixed-effects specification not otherwise detailed.",
      "Confidence Rating": "Medium",
      "Negative Answer Category": "Unclear/Incomplete",
      "Reason": "Paper specifies predictors but not effect type (fixed/random) in the normative model; single-site so no site effects considered.",
      "Supporting Text": "Quantile regression … as a function of age and sex … (no statement on effect type).",
      "Page/Line": "materials/Zheng2024.pdf.md: line 116"
    },
    "nm_vldtn_handle_ns": {
      "Answer": "Single-site acquisition avoids inter-site batch effects; quantile modeling captures age-related trends; TIV included as covariate in downstream analyses; no explicit modeling of heteroscedasticity beyond quantiles.",
      "Confidence Rating": "Medium",
      "Negative Answer Category": "Not Negative",
      "Reason": "Nuisance structures like site/scanner variance are minimized by single-site design; age and sex handled in model; TIV addressed in analysis.",
      "Supporting Text": "Single 3.0T scanner at one site … Quantile regression … function of age and sex … TIV … used as a covariate …",
      "Page/Line": "materials/Zheng2024_sup.pdf.md: lines 27-33; 31-33; materials/Zheng2024.pdf.md: line 116"
    },
    "nm_vldtn_same_domain_nonindep": {
      "Answer": "Subtyping stability assessed via Adjusted Rand Index (ARI) with 10-fold cross-validation and 1000 permutations within discovery dataset.",
      "Confidence Rating": "High",
      "Negative Answer Category": "Not Negative",
      "Reason": "Explicit description of ARI-based internal validation with resampling.",
      "Supporting Text": "… chose the clustering solution with the highest averaged ARI following 10-fold cross-validation with 1000 times permutations …",
      "Page/Line": "materials/Zheng2024.pdf.md: lines 120-124"
    },
    "nm_vldtn_same_domain_indep": {
      "Answer": "No",
      "Confidence Rating": "Low",
      "Negative Answer Category": "Missing",
      "Reason": "No explicit held-out independent subset within the same domain reported for normative model evaluation.",
      "Supporting Text": "Internal validation described for clustering stability only; no held-out test set mentioned for normative fit.",
      "Page/Line": "materials/Zheng2024.pdf.md: lines 120-124 (no hold-out described)"
    },
    "nm_vldtn_diff_domain": {
      "Answer": "Partial",
      "Confidence Rating": "Medium",
      "Negative Answer Category": "Unclear/Incomplete",
      "Reason": "Replication performed in an independent medicated patient cohort from the same site/scanner (different cohort but not multi-site external domain).",
      "Supporting Text": "We also validated the GMV deviations based subtyping analysis in a replication cohort … 174 drug-free patients constitute the discovery dataset … 268 medicated patients comprise the validated dataset …",
      "Page/Line": "materials/Zheng2024.pdf.md: lines 100-108; 122-124"
    }
  },
  "clinical_application_and_analysis": {
    "clinical_dataset": {
      "Answer": "Discovery: 174 drug-naïve/drug-free MDD/BD; HC=404. Replication: 268 medicated MDD/BD (same site).",
      "Confidence Rating": "High",
      "Negative Answer Category": "Not Negative",
      "Reason": "Discovery and replication cohort compositions are clearly stated.",
      "Supporting Text": "We recruited 114 MDD, 60 BD and 404 HC … We also validated … in a replication cohort … 268 medicated patients …",
      "Page/Line": "materials/Zheng2024.pdf.md: lines 69-76; 100-108; 122-124"
    },
    "diseases_studied": {
      "Answer": "Major Depressive Disorder (MDD); Bipolar Disorder (BD)",
      "Confidence Rating": "High",
      "Negative Answer Category": "Not Negative",
      "Reason": "Diseases explicitly named throughout.",
      "Supporting Text": "… patients with major depressive disorder and bipolar disorder …",
      "Page/Line": "materials/Zheng2024.pdf.md: lines 47-55; 69-76"
    },
    "clinical_groups_n": {
      "Answer": "MDD 114; BD 60 (discovery)",
      "Confidence Rating": "High",
      "Negative Answer Category": "Not Negative",
      "Reason": "Group sizes reported in text/table.",
      "Supporting Text": "We recruited 114 MDD patients, 60 BD patients … Table S1 … N=114 (MDD), N=60 (BD)",
      "Page/Line": "materials/Zheng2024.pdf.md: line 69; materials/Zheng2024_sup.pdf.md: lines 66-70"
    },
    "clinical_groups_age": {
      "Answer": "MDD 28.7±11.1; BD 27.8±8.5 (years, mean±SD)",
      "Confidence Rating": "High",
      "Negative Answer Category": "Not Negative",
      "Reason": "Ages for MDD and BD groups provided in Table S1.",
      "Supporting Text": "Table S1 … Age | 28.7±11.1 (MDD); 27.8±8.5 (BD)",
      "Page/Line": "materials/Zheng2024_sup.pdf.md: lines 66-72"
    },
    "clinical_groups_sex": {
      "Answer": "MDD: M 34 (29.8%), F 80 (70.2%); BD: M 23 (38.3%), F 37 (61.7%)",
      "Confidence Rating": "High",
      "Negative Answer Category": "Not Negative",
      "Reason": "Sex counts provided; percentages computed from group Ns.",
      "Supporting Text": "Table S1 … Gender (male/female) | 34/80 (MDD); 23/37 (BD)",
      "Page/Line": "materials/Zheng2024_sup.pdf.md: lines 66-73"
    },
    "deviation_metric": {
      "Answer": "Normative deviation z-scores from quantile regression percentiles (z5, z50, z95); classification of supra/infra-normal using |z|>1.96; z50 maps used for clustering.",
      "Confidence Rating": "High",
      "Negative Answer Category": "Not Negative",
      "Reason": "Deviation definitions and thresholds explicitly described.",
      "Supporting Text": "… expressed … z5 … z50 … z95 … as individual deviation z-scores … (z95 > 1.96, z5 < -1.96) … z50 maps … used to perform subtyping …",
      "Page/Line": "materials/Zheng2024.pdf.md: lines 116-132"
    },
    "association_analysis": "Between-subtype comparisons of clinical symptoms (HAMD/HAMA/BPRS) and cognition (WCST); construction and comparison of symptom networks via graph theory (density/strength); imaging transcriptomics using AHBA with PLS and pathway/cell-type enrichment; polygenic risk scores (PRS) for AD and MDD computed via PRSice and compared between subtypes.",
    "key_findings_brief": "Two subtypes emerged: subtype 1 showed increased frontal GMV deviations with poorer cognitive performance and higher AD genetic risk, while subtype 2 showed globally decreased GMV deviations with more severe depressive symptoms and higher MDD genetic risk; regional deviation patterns replicated in an independent cohort.",
    "key_findings_detailed": "Subtyping of 174 drug-free patients yielded subtype 1 (n=112) with supra-normal deviations in frontal/cingulate/paracentral cortex and subtype 2 (n=62) with widespread infra-normal deviations (and occipital supra-normal). Subtype 2 had higher HAMD total (23.82±8.9) than subtype 1 (20.08±7.5; t=2.67, PFDR=0.025). Subtype 1 showed worse WCST performance vs HC (e.g., WCST-PE t=4.00, PFDR=0.001), while subtype 2 did not differ from HC. Symptom network density/strength were higher in subtype 2 (0.51/6.76) vs subtype 1 (0.42/5.24). Gene enrichment associated subtype 1 with AD-related pathways and oligodendrocyte/endothelial cell signatures, and subtype 2 with microglia/inhibitory neuron signatures. PRS analyses indicated higher AD risk in subtype 1 and higher MDD risk in subtype 2. Regional z50 deviation maps correlated across discovery and replication cohorts (r=0.29, p<0.05 in subtype 1; r=0.45, p<1e-4 in subtype 2).",
    "key_limitations": "Use of AHBA gene expression from healthy brains may not reflect patient transcription; limited right-hemisphere coverage in AHBA; relatively small genetic sample size; cognitive assessment limited to WCST; lacked specific data on first-episode illness severity.",
    "application_notes": "Demonstrates normative modeling-based subtyping integrating imaging, symptoms, transcriptomics, and PRS; clustering stability assessed via ARI with cross-validation; replication in independent medicated cohort from same site."
  },
  "general_notes": {
    "general_notes": "Single-site 3.0T GE Signa HDx; CAT12/SPM12 preprocessing with DARTEL; DK-68 ROI summarization; TIV used as covariate in analyses; no site harmonization needed due to single-site design."
  }
}

